Article Text

Download PDFPDF
Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial
  1. P W Y Chiu,
  2. C Y W Lam,
  3. S W Lee,
  4. K H Kwong,
  5. S H Lam,
  6. D T Y Lee,
  7. S P Y Kwok
  1. Department of Surgery and Endoscopy Centre, United Christian Hospital, Kwun Tong, Hong Kong SAR, China
  1. Correspondence to:
    Dr P W Y Chiu, Surgery, United Christian Hospital, 130 Hip Woo St, Kwun Tong, Hong Kong SAR, China;
    pchiu{at}hkstar.com

Abstract

Aim: Recurrent bleeding after initial haemostasis is an important factor that directly relates to the outcome in the management of peptic ulcer bleeding. Conflicting reports have been published concerning the effectiveness of scheduled second therapeutic endoscopy on ulcer rebleeding. We investigate the use of scheduled second endoscopy with appropriate therapy on peptic ulcer rebleeding.

Methods: From August 1999 to January 2001, we prospectively randomised patients who had endoscopically confirmed bleeding peptic ulcer with stigmata of acute bleeding, visible vessel, or adherent clot into two groups. Endoscopic therapy was standardised to initial epinephrine injection and subsequent heater probe application. The study group (n = 100) received scheduled second endoscopy 16–24 hours after initial haemostasis, and further therapy was applied if endoscopic stigmata persisted, as above. The control group (n = 94) were observed closely. Those patients that developed rebleeding in either group underwent operation if further endoscopic therapy failed. Outcome measures included ulcer rebleeding, transfusion, duration of stay, and mortality.

Results: After initial endoscopic haemostasis, 194 eligible patients were randomised into two groups. Thirteen patients in the control group developed recurrent bleeding within 30 days while five patients in the study group sustained recurrent bleeding (p = 0.0314) (relative risks 0.33, 95% confidence interval 0.1–0.96). The number of patients that required surgery for recurrent bleeding was six in the control group and one in the study group (p = 0.05). There was no difference in duration of hospital stay, transfusion, or mortality between the two groups.

Conclusions: A scheduled repeat endoscopy with appropriate therapy 16–24 hours after initial endoscopic haemostasis reduces the number of cases of recurrent bleeding.

  • peptic ulcer bleeding
  • scheduled second endoscopy
  • therapeutic endoscopy
  • ulcer rebleeding

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles

  • Digest
    Robin Spiller